Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The adrenergic nerve terminal is the specialized region at the end of an adrenergic nerve fiber where neurotransmitters—primarily norepinephrine (noradrenaline), and to a lesser extent epinephrine (adrenaline) and dopamine—are released into the synaptic cleft. These terminals are found in secondary neurons of the sympathetic nervous system, which is responsible for mediating the "fight-or-flight" response. The neurotransmitters released from these terminals bind to adrenergic receptors on target tissues, leading to various physiological effects such as increased heart rate, vasoconstriction, pupil dilation, and modulation of glandular secretions. Drugs targeting adrenergic nerve terminals or their associated receptors play major roles in treating cardiovascular diseases like hypertension, arrhythmias, angina pectoris; they also have applications in managing asthma (via beta agonists). Dysregulation can contribute to conditions such as heart failure or hypertension due to excessive sympathetic activity.
Modulation of neurotransmitter release and receptor activation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adrenergic Nerve Terminal (None).